Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma

被引:8
作者
Bahng, Agnes Y. [1 ]
Chu, Christina [2 ]
Wileyto, Paul [3 ]
Rubin, Stephen [2 ]
Lin, Lilie L. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Biostat, Philadelphia, PA 19104 USA
关键词
Chemotherapy; Endometrial neoplasms; High intermediate risk; Radiotherapy; PHASE-III TRIAL; STAGE-I; ADJUVANT RADIOTHERAPY; VAGINAL BRACHYTHERAPY; PELVIC RADIOTHERAPY; SPACE INVOLVEMENT; RADIATION-THERAPY; GRADE; CARCINOMA; CANCER;
D O I
10.3802/jgo.2012.23.4.257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma. Methods: A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral salpingo-oophorectomy, with or without pelvic/para-aortic lymphadenectomy at the University of Pennsylvania between 1990 and 2009 was performed. Results: A total of 103 women with HIR endometrial cancer were identified. Multivariable analysis revealed that >= 2/3 myometrial invasion (HR, 4.79; p=0.010) and grade 3 disease (HR, 3.04; p=0.045) were independently predictive of distant metastases. The 5-year distant metastases free survival (DMFS) for patients with neither or one of these risk factors was 89%, and the 5-year DMFS for patients with both risk factors was 48% (p<0.001). Conclusion: Patients with both grade 3 disease and deep third myometrial invasion have a high risk of distant metastases. Identifying these patients may be important in rationally selecting patients for systemic therapy.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 41 条
  • [1] AALDERS J, 1980, OBSTET GYNECOL, V56, P419
  • [2] [Anonymous], END CANC
  • [3] Lymphvascular space involvement:: an independent prognostic factor in endometrial cancer
    Briët, JM
    Hollema, H
    Reesink, N
    Aalders, JG
    Mourits, MJE
    ten Hoor, KA
    Pras, E
    Boezen, HM
    van der Zee, AGJ
    Nijman, HW
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 799 - 804
  • [4] Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy
    Chadha, M
    Nanavati, PJ
    Liu, P
    Fanning, J
    Jacobs, A
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 75 (01) : 103 - 107
  • [5] Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma
    Convery, Patricia A.
    Cantrell, Leigh A.
    Di Santo, Nicola
    Broadwater, Gloria
    Modesitt, Susan C.
    Secord, Angeles Alvarez
    Havrilesky, Laura J.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 65 - 70
  • [6] Carcinoma of the corpus uteri
    Creasman, W. T.
    Odicino, F.
    Maisonneuve, P.
    Quinn, M. A.
    Beller, U.
    Benedet, J. L.
    Heintz, A. P. M.
    Ngan, H. Y. S.
    Pecorelli, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 : S105 - S143
  • [7] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
  • [8] 2-8
  • [9] Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients:: The postoperative radiation therapy in endometrial carcinoma trial
    Creutzberg, CL
    van Putten, WLJ
    Wárlám-Rodenhuis, CC
    van den Bergh, ACM
    De Winter, KAJ
    Koper, PCM
    Lybeert, MLM
    Slot, A
    Lutgens, LCHW
    Kroese, MCS
    Beerman, H
    van Lent, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1234 - 1241
  • [10] Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
    Creutzberg, CL
    van Putten, WLJ
    Koper, PCM
    Lybeert, MLM
    Jobsen, JJ
    Wárlám-Rodenhuis, CC
    De Winter, KAJ
    Lutgens, LCHW
    van den Bergh, ACM
    van de Steen-Banasik, E
    Beerman, H
    van Lent, M
    [J]. LANCET, 2000, 355 (9213) : 1404 - 1411